Cargando…
Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders
Childhood neurotransmitter disorders are increasingly recognised as an expanding group of inherited neurometabolic syndromes. They are caused by disturbance in synthesis, metabolism, and homeostasis of the monoamine neurotransmitters, including the catecholamines (dopamine, norepinephrine, and epine...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102824/ https://www.ncbi.nlm.nih.gov/pubmed/25011953 http://dx.doi.org/10.1007/s40272-014-0079-z |